HF
IRMD icon

HRT Financial’s iRadimed IRMD Stock Holding History

HRT Financial’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.7M Sell
38,678
-8,859
-19% -$807K 0.01% 1335
2026
Q1 		$4.58M Buy
47,537
+20,967
+79% +$2.1M 0.01% 1054
2025
Q4 		$2.58M Buy
26,570
+6,783
+34% +$582K 0.01% 1136
2025
Q3 		$1.41M Buy
+19,787
New +$1.32M 0.01% 1347
2025
Q1 		– Sell
-5,039
Closed -$277K – 2931
2024
Q4 		$277K Sell
5,039
-3,500
-41% -$184K ﹤0.01% 1759
2024
Q3 		$429K Sell
8,539
-7,467
-47% -$344K ﹤0.01% 1656
2024
Q2 		$703K Buy
16,006
+10,494
+190% +$446K ﹤0.01% 1156
2024
Q1 		$242K Buy
+5,512
New +$244K ﹤0.01% 1666

Other funds holding IRMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

HRT Financial's IRMD Position: Q2 2026 in Review

HRT Financial reduced its iRadimed (IRMD) stake by 19% in Q2 2026, selling an estimated $807K and leaving 38,678 shares worth $3.7M. The position accounts for 0.01% of the portfolio, ranked #1335.

HRT Financial first reported a position in IRMD in Q1 2024 and has held it in 8 quarters since. The position peaked at $4.58M in Q1 2026. 214 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.

  • HRT Financial held 38,678 shares of iRadimed worth $3.7M as of Q2 2026.
  • HRT Financial sold 8,859 iRadimed shares in Q2 2026, an estimated $807K.
  • iRadimed made up 0.01% of HRT Financial's portfolio in Q2 2026, its #1335 holding.
  • HRT Financial first reported a position in iRadimed in Q1 2024 and has held it in 8 quarters since.
  • HRT Financial's iRadimed position peaked at $4.58M in Q1 2026.
  • 214 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.